Logo image of SPRC

SCISPARC LTD (SPRC) Stock Fundamental Analysis

NASDAQ:SPRC - Nasdaq - IL0010951403 - Common Stock - Currency: USD

0.3075  0 (-0.81%)

After market: 0.3005 -0.01 (-2.28%)

Fundamental Rating

2

Taking everything into account, SPRC scores 2 out of 10 in our fundamental rating. SPRC was compared to 198 industry peers in the Pharmaceuticals industry. SPRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SPRC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SPRC has reported negative net income.
SPRC had a negative operating cash flow in the past year.
In the past 5 years SPRC always reported negative net income.
In the past 5 years SPRC always reported negative operating cash flow.
SPRC Yearly Net Income VS EBIT VS OCF VS FCFSPRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -46.15%, SPRC is in line with its industry, outperforming 43.43% of the companies in the same industry.
SPRC's Return On Equity of -67.77% is in line compared to the rest of the industry. SPRC outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -46.15%
ROE -67.77%
ROIC N/A
ROA(3y)-42.86%
ROA(5y)-136.21%
ROE(3y)-59.52%
ROE(5y)-9664.38%
ROIC(3y)N/A
ROIC(5y)N/A
SPRC Yearly ROA, ROE, ROICSPRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K -40K

1.3 Margins

SPRC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPRC Yearly Profit, Operating, Gross MarginsSPRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

4

2. Health

2.1 Basic Checks

SPRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPRC has been increased compared to 1 year ago.
SPRC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPRC has a worse debt to assets ratio.
SPRC Yearly Shares OutstandingSPRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
SPRC Yearly Total Debt VS Total AssetsSPRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

SPRC has an Altman-Z score of -7.10. This is a bad value and indicates that SPRC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -7.10, SPRC is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
SPRC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SPRC has a better Debt to Equity ratio (0.00) than 62.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.1
ROIC/WACCN/A
WACC9.13%
SPRC Yearly LT Debt VS Equity VS FCFSPRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 4.10 indicates that SPRC has no problem at all paying its short term obligations.
SPRC has a better Current ratio (4.10) than 66.67% of its industry peers.
SPRC has a Quick Ratio of 3.63. This indicates that SPRC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.63, SPRC is in the better half of the industry, outperforming 64.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 3.63
SPRC Yearly Current Assets VS Current LiabilitesSPRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.22% over the past year.
SPRC shows a strong growth in Revenue. In the last year, the Revenue has grown by 113.26%.
EPS 1Y (TTM)36.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.64%
Revenue 1Y (TTM)113.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPRC Yearly Revenue VS EstimatesSPRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 500K 1M 1.5M 2M 2.5M
SPRC Yearly EPS VS EstimatesSPRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SPRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPRC Price Earnings VS Forward Price EarningsSPRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPRC Per share dataSPRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SPRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCISPARC LTD

NASDAQ:SPRC (5/23/2025, 8:56:50 PM)

After market: 0.3005 -0.01 (-2.28%)

0.3075

0 (-0.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.33M
AnalystsN/A
Price TargetN/A
Short Float %3.24%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0
BVpS0.7
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.15%
ROE -67.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.86%
ROA(5y)-136.21%
ROE(3y)-59.52%
ROE(5y)-9664.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 3.63
Altman-Z -7.1
F-Score3
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)898.83%
Cap/Depr(5y)539.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)113.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.67%
OCF growth 3YN/A
OCF growth 5YN/A